Survival analyses indicated no difference in the association of APOE*44 with AD risk across Black (hazard ratio [HR], 2.23; 95% CI, 2.07-2.40) and White (HR, 2.32; 95% CI, 2.27-2.38) individuals. Here, APOE is linked to Alzheimer disease.